Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
3,3'-(Biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonic acid)
Potential treatment - theoretical effect Experimental Antiviral Mar/26/2021
N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
2-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-N-(3-methylphenyl)quinazolin-4-amine
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
Gallic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Caerin 1.10
Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020
Caerin 1.6
Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020
Irbesartan
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Alvimopan
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Hypericin
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Darifenacin
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte
Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020
Tolazamide
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
(1,3-Dimethylpyrazol-4-yl)-[4-(4-fluorophenyl)piperazin-1-yl]methanone
Potential treatment - theoretical effect Experimental Antiviral Oct/23/2020
Silodosin
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/25/2020
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
ZINC104875569
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
Adenosine diphosphate ribose
Potential treatment - theoretical effect Natural product Antiviral Sep/08/2020
4-(3,4-Dihydroxyphenyl)-7-methoxy-5-[(2S,3R,4S,5S)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one
Potential treatment - theoretical effect Natural product Antiviral Sep/08/2020
Leuprorelin
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020
Lypressin
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020